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Abstract
Introduction
Phenols are a large family of natural and synthetic compounds with known antioxidant activity. The
aim of this study was to preform an in vitro screening of natural and natural-like phenol monomers
and their C2-symetric dimers (hydroxylated biphenyls) in order to identify those representatives
which pharmacophores have the strongest antioxidant and the lowest prooxidant activity.
Material and methods
Antioxidative properties of 36 compounds (monomers and their C2-symmetric dimers) were
evaluated in vitro. Different (red/ox) assays were used to measure their total oxidative potential
(TOP), their total antioxidative capacity (TAC), the pro-oxidative-antioxidant balance (PAB) and total
SH-group content (SHG) in a biologically relevant environment. The Pro-oxidative Score,
Antioxidative Score and the Oxy Score were also calculated. Trolox, a water soluble analogue of α-
tocopherol was used as a positive control.
Results
In an assay consisting of pooled human serum 6 of the 36 compounds indicated significant
antioxidant activity (compounds 6, 7, 12, 13, 26, and 27) whereas 4 indicated extremely weak
antioxidant activity (compounds 2, 29, 30, and 31). Within the 36 compounds comprising of
zingerone, dehydrozingerone, aurone, chalcone, magnolol derivatives, in both monomeric and
dimeric forms, the 2 compounds that indicated the highest antioxidant activity were
dehydrozingerone derivatives (compounds 6 and 12). Trolox’s activity was found between the strong
and weak antioxidant compounds analysed in our study.
Conclusions
In this study selected dehydrozingerones were identified as good candidates for in-depth testing of
their biological behaviour and for possible precursors for the synthesis of novel polyphenolic
molecules with potential therapeutic applications.







Introduction: Phenols are a large family of natural and synthetic compounds with known 
antioxidant activity. The aim of this study was to preform an in vitro screening of natural and 
natural-like phenol monomers and their C2-symetric dimers (hydroxylated biphenyls) in order 
to identify those representatives which pharmacophores have the strongest antioxidant and the 
lowest prooxidant activity. 
Material and Methods: Antioxidative properties of 36 compounds (monomers and their C2-
symmetric dimers) were evaluated in vitro. Different (red/ox) assays were used to measure their 
total oxidative potential (TOP), their total antioxidative capacity (TAC), the pro-oxidative-
antioxidant balance (PAB) and total SH-group content (SHG) in a biologically relevant 
environment. The Pro-oxidative Score, Antioxidative Score and the Oxy Score were also 
calculated. Trolox, a water soluble analogue of α-tocopherol was used as a positive control. 
Results: In an assay consisting of pooled human serum 6 of the 36 compounds indicated 
significant antioxidant activity (compounds 6, 7, 12, 13, 26, and 27) whereas 4 indicated 
extremely weak antioxidant activity (compounds 2, 29, 30, and 31). Within the 36 compounds 
comprising of zingerone, dehydrozingerone, aurone, chalcone, magnolol derivatives, in both 
monomeric and dimeric forms, the 2 compounds that indicated the highest antioxidant activity 
were dehydrozingerone derivatives (compounds 6 and 12). Trolox’s activity was found between 
the strong and weak antioxidant compounds analysed in our study. 
Conclusion: In this study selected dehydrozingerones were identified as good candidates for 
in-depth testing of their biological behaviour and for possible precursors for the synthesis of 
novel polyphenolic molecules with potential therapeutic applications. 















Phenols are a large family of natural and synthetic compounds with known antioxidant activity 
[1, 2]. A deficit in antioxidant protection and/or excessive production of reactive oxygen species 
(ROS) in cells causes oxidative stress which is detrimental to living organisms [3]. Natural 
phenols are recognized as nutraceuticals, active components of functional food, often used as 
adjuvants in therapy, or in prevention of different diseases such as cardiovascular diseases [4], 
dyslipidemia [5], neurodegenerative diseases [6,7], and bacterial and viral infections. [8,9,10] 
Despite the promising therapeutical and/or preventive effects and high safety profile, their use 
is limited, mainly because of their poor bioavailability. [4] Therefore, the use of sinthesized 
natural-like derivatives has potential to overcome this limitation. 
So far, the most interest has been shown for derivatives of zingeron and curcumin. [11,12].  
Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] is an active ingredient isolated from 
dried or heat-treated ginger (Zingiber officinale, family Zingiberaceae). Curcumin [1,7-bis(4-
hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is an active component of the root of 
turmeric plant (Curcuma longa Linn, family Zingiberaceae).  
Hydroxylated biphenyls are examples of natural plant-derived polyphenols. Due to their ability 
to bind to many types of proteins hydroxylated biphenyls could therefore affect biological 
processes within living organisms [13, 14]. The most important pharmacophore in their 
structure consists of the two benzene rings bridged by a single covalent bond. The presence of 
steric hindrance caused by chemical groups positioned close to the single C-C bond can lead to 
interactions between biphenyl structures and proteins via selective chiral recognition [1, 15, 
16]. A C2-symmetry axis in the structure allows the two aromatic rings indistinguishable. This 
axis facilitates the synthesis of compounds and their interactions with proteins. Due to their 
specific structure, hydroxylated biphenyls can reduce oxidative stress to an extent greater than 
both their corresponding natural and synthetic monophenols [17]. The antioxidative activity of 
hydroxylated biphenyls increases when the phenol hydroxyl groups are located in orthoposition 
to the single C-C bond between the two aromatic rings as it influences intramolecular hydrogen 
bonding and stabilisation of the generated phenoxyl radical [1, 18]. The presence of a methoxyl 
group in ortho position to the phenolic hydroxyl group (a guaiacyl unit) and an α,β-unsaturated 
chain in 4 position provides even better stabilisation of the generated phenoxyl radical [17, 18].  
Phenols, in addition to be antioxidants, can also exhibit pro-oxidant characteristics. Under 






oxidative due to their rapid conversion back to non-radicals via polymerisation, enzymatic or 
non-enzymatic radical reduction reactions. However, phenoxyl radicals can exhibit cytotoxic 
pro-oxidative activity in the case of free radical life prolongation [19].  
As phenols form the core in the structure of numerous drug molecules, diverse group of 
phenolic compounds, including natural and natural-like monomers and their C2-symetric 
dimers (hydroxylated biphenyls) was formed, and their effect on oxidative stress was 
investigated in this study. The antioxidative capability of selected monomers and their C2 
symmetric dimers was determined using a number of in vitro assays. Moreover, the way 
different phenolic structures behave in biological matrix (blood serum) in regards to their 
interactions, conformational changes and formation of hydrogen bonds was analyzed. Many of 
the compounds were synthesized for the first time ever. 
The goal of this study was to identify those representatives which pharmacophores have the 
strongest antioxidant and the lowest prooxidant activity in vitro conditions and thus conclude 
which phenolic pharmacophore is the most promising for potential further drug development, 










Materials and Methods 
Reagents and solvents, were of analytical reagent grade and bought from Aldrich Chemie 
(Steinheimm, Germany) and Merck (Darmstadt, Germany). 
Compounds 3 and 32 were purchased from Chemos GmbH (Regenstauf, Germany), 






purification. Compounds 4 and 6-9 were prepared according procedures described by 
Marchiani et al. [21], compound 10 as described by Cook et al. [22], compound 12 as 
described by Choi et al. [23], compound 16 as described by Tatzuzaki et al. [24], compound 
18 as described by Varro et al [25], compounds 20, 21 and 41 as described by Dettori et al 
[26], compound 42 as described by Oufensou et al [27], compound 33 as described by Lin et 
al. [28], compound 34 as described by Kong et al. [29], and compounds 35, 36 as described 
by Maioli et al. [15]. 
The purity of all new compounds was judged to be >98% by 1H NMR and 13C NMR spectral 
determination.  
Lipophilicity of compounds 1-36 was estimated by ChemBioDraw Ultra 13.0 software 
(Cambridge Soft) using the logarithm of the partition coefficient for n-octanol/water (LogP) 
and listed in Table I. 
Analysis of antioxidant activity was performed by using a microplate reader (BioTek, 
Winooski, Vermont, USA) and ILAB 300+ automatic analyzer (Instrumentation Laboratory, 
Milan, Italy). Melting points were estimated with a Büchi 530 melting point apparatus in open 
capillaries and are uncorrected. All 1H NMR and 13C NMR spectra were acquired with a Varian 
VXR 5000 spectrometer at 399.94 MHz and 75.42 MHz respectively; , all spectra were run at 
room temperature in CDCl3 solution (if not otherwise indicated). Chemical shifts are reported 
in ppm () on scale downfield from TMS as internal standard. Signal patterns are indicated as 
s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) or dd (double of doublets). 
Determination of elemental analyses was done using an elemental analyser Perkin-Elmer model 
240 C. Acetone was distilled from CaCl2. Purification was achieved by silica gel column 
chromatography using silica gel 60 (230-400 mesh, Kiesgel, EM Reagents) eluting with 
appropriate solution in the stated v:v proportions. Reaction progress was monitored by thin 
layer chromatography, 0.25 mm thick pre-coated silica plates (PolygramSil G/UV254, 
Macherey-Nagel) and spots were detected under UV light.  







Neutral alumina (13 g) is added to a solution of 4-methoxybenzaldehyde (0.88 g, 6.46 mmol) 
and 5,6-dimethoxybenzofuran-3(2H)-one [30] (0.42 g, 2.15 mmol) in dichloromethane (10 
mL). The reaction mixture was thoroughly mixed at room temperature for 6 hrs. The solvent 
was rotoevaporated, to give the solid product which was purified by crystallization from 
dichloromethane-petroleum ether to afford 1 as a yellow solid (0.41 g, 60%): mp 199–200 °C 
(lit54 199-201); 1H NMR  3.86 (s, 3H), 3.91 (s, 3H), 4.01 (s, 3H), 6.81 (s, Hz, Ar, 1H), 6.82 (s, 
1H), 6.96 (d, J = 8.8 Hz, Ar, 2H), 7.18 (s, Ar,1H), 7.85 (d, J = 8.8 Hz, Ar, 2H); 13C NMR  
55.34, 56.31, 56.61, 95.51, 103.90, 112.29, 113.01, 114.37, 125.15, 133.15, 146.47, 146.88, 







Neutral alumina (2 g) is added to a solution of 4-methoxybenzaldehyde (0.13 g, 1 mmol) and 
compound 37 (0.13 g, 0.33 mmol) in dichloromethane (10 mL). The reaction mixture was 
thoroughly mixed at room temperature for 6 hrs. Removal of the solvent yielded the solid 
product which was purified by crystallization from dichloromethane-petroleum ether to afford 
2 as a yellow solid (0.12 g, 59%): mp 190–191 °C; 1H NMR  3.63 (s, 6H), 3.84 (s, 6H), 4.01 
(s, 6H), 6.61 (s, 2H), 6.91 (s, Ar, 2H), 6.94 (d, J = 8.4 Hz, Ar, 4H), 7.80 (d, J = 8.4 Hz, Ar, 4H); 
13C NMR  55.33, 56.35, 61.06, 96.07, 111.61, 112.41, 114.32, 124.97, 125.35, 132.98, 143.51, 
146.91, 160.31, 160.59, 164.15, 182.23; Anal. Calcd. for C36H30O10: C, 69.45; H, 4.86; Found: 









To a solution of compound 38 (0.21 g, 0.89 mmol) in dichloromethane (15 mL), a solution of 
molybdenum (V) chloride (0.48 g, 1.78 mmol) in dichloromethane (10 mL) was added  at 0 °C 
and under N2. The mixture was stirred at 0 °C for 45 m. Water was cautiously added. The 
solution was extracted with dichloromethane and dried over Na2SO4. The crude product was 
purified by column chromatography using a 1:1 mixture of petroleum: acetone as eluent, to give 
5 as a yellow oil (2.16 g, 60%): 1H NMR  1.99 (s, 6H), 2.60-2.73 (series of m, 8H), 3.87 (s, 
6H), 6.62 (s, Ar, 2H), 6.71 (s, Ar, 2H); 13C NMR  27.05, 29.87, 45.12, 55.91, 111.34, 116.18, 
130.62, 132.97, 143.38, 145.81, 208.35; Anal. Calcd.for C22H26O6: C, 62.55; H, 5.14; Found: 




To a solution of 10 (1.6 g, 10.1 mmol) in dry dichloromethane (20 mL), methyl-
tributylammonium permanganate (MTBAP) [31] (1.61 g, 5.05 mmol) in dry dichloromethane 
(15 mL) was added dropwise at room temperature and under N2  . The solution was stirred at 
room temperature for 30 min. An aqueous solution of Na2S2O5 (50 mL) was added. The organic 
layer was separated, washed with water, dried over Na2SO4 and evaporated to afford 11 as a 
white solid. Flash chromatography using a 1:2 mixture of ethyl acetate: petroleum ether as 
eluent gave 11 as white solid (1.03 g, 61%): mp 103–104 °C; 1H NMR  3.31 (s, 6H), 3.87 (s, 
6H), 5.37 (s, 4H), 6.85 (d, J = 2 Hz, Ar, 2H), 6.94 (d, J = 2 Hz, Ar, 2H); 13C NMR  55.51, 
56.86, 74.20, 110.96, 122.93, 125.02, 129.39, 143.22, 147.73; Anal. Calcd. for C18H22O6: C, 











An aqueous solution (1 N) of LiOH (40 mL, 40.0 mmol) was added dropwise to a stirred 
solution of 39 (2.17 g, 6.6 mmol) in acetone (50 mL) at room temperature and under N2.. The 
mixture was stirred at 60°C for 12 hrs, 10 % HCl and water were cautiously added. The resulting 
precipitate was filtered, washed with water and dried with Na2SO4. The  product was purified 
by column chromatography using a 1:1 mixture of petroleum:ethyl acetate as eluent, to obtain 
13 as a yellow solid (2.16 g, 80%): mp = 100-101°C; 1H NMR  1.50 (t, J = 6.4 Hz, 6H), 2.35 
(s, 6H), 4.20 (q, J = 6.4 Hz, 4H), 6.20 (bs, 2H), 6.59 (d, J = 16.4 Hz, 2H), 7.01 (d, J = 1.6 Hz, 
Ar, 2H), 7.17 (d, J = 1.6 Hz, Ar, 2H), 7.47 (d, J = 16.4 Hz, 2H); 13C NMR  14.81, 27.32, 56.01, 
109.55, 123.56, 125.16, 125.28, 126.40, 143.69, 145.63, 146.55, 198.38; Anal. Calcd. for 
C24H26O6: C, 70.23; H, 6.38; Found: C, 70.24; H, 6.32. 
 
General procedure of the phenolic-OH group protection (compounds 14, 15, 17,19, 40) 
To a solution of phenol or biphenol (one equivalent) and K2CO3 (1.1 equivalents for monomer, 
2.2 for dimers) in dry acetone, alkyl halide (methyl iodide or ethyl bromide or allyl bromide) 
(1.1 equivalents for monomer, 2.2 for dimers) was added under N2 at room temperature. The 
reaction mixture was stirred at 56°C for 12 hrs. Acetone was evaporated and 10 % HCl and 
water were added. The solution was extracted with diethyl ether, dried over Na2SO4 and 





From 12, compound 14 was achieved after flash chromatography (ethyl acetate:petroleum ether 
1:5) as a yellow solid (0.42 g, 92%): mp 145–147 °C; 1H NMR  1.49 (t, J = 6.8 Hz, 3H), 2.35 
(s, 3H), 3.92 (s, 3H), 4.13 (q, J = 6.8 Hz, 2H), 6.61 (d, J = 16.4 Hz, 1H), 6.87 (d, J = 8.4 Hz, 
Ar, 1H), 7.07 (d, J = 2 Hz, Ar, 1H), 7.15 (dd, J = 2, 8.4 Hz, 1H), 7.45 (d, J = 16.4 Hz, 1H); 13C 
NMR  14.72, 27.33, 56.01, 64.36, 110.97, 111.23, 122.91, 125.17, 127.25, 143.66, 148.57, 




From 13, compound 15 was achieved after a flash chromatography (ethyl acetate:petroleum 






2.34 (s, 6H), 3.72 (s, 6H), 4.13 (q, J = 7.2 Hz, 4H), 6.62 (d, J = 16.4 Hz, 2H), 7.03 (d, J = 2 Hz, 
Ar, 2H), 7.10 (d, J = 2 Hz, Ar, 2H), 7.45 (d, J = 16.4 Hz, 2H); 13C NMR  14.88, 27.47, 60.81, 
64.47, 111.93, 124.05, 126.35, 129.66, 132.43, 143.21, 149.27, 152.31, 198.29; Anal. Calcd. 




From 7, compound 17 was achieved after a flash chromatography (ethyl acetate:petroleum ether 
1:2) as a yellow solid (0.82 g, 89%): mp 138–139 °C; 1H NMR  1.09 (t, J = 7.2 Hz, 6H), 2.36 
(s, 6H), 3.87-4.01 (series of m, 10H), 6.62 (d, J = 16 Hz, 2H), 7.10 (m, Ar, 4H), 7.45 (d, J = 16 
Hz, 2H); 13C NMR  15.56, 27.50, 55.94, 69.16, 110.60, 124.41, 126.29, 129.50, 132.79, 
143.21, 148.39, 153.22, 198.29; Anal. Calcd. for C26H30O6: C, 71.21; H, 6.90; Found: C, 71.29; 




From 13, compound 19 was achieved after a flash chromatography (ethyl acetate:petroleum 
ether 2:3) as a yellow solid (0.78 g, 80%): mp 143–144 °C; 1H NMR  1.11 (t, J = 7.2 Hz, 6H), 
1.49 (t, J = 7.2 Hz, 6H), 2.35 (s, 6H), 3.92 (q, J = 7.2 Hz, 4H), 4.13 (q, J = 7.2 Hz, 4H), 6.63 
(d, J = 16 Hz, 2H), 7.08 (d, J = 2.4 Hz, Ar, 2H), 7.10 (d, J = 2.4 Hz, Ar, 2H), 7.44 (d, J = 16 
Hz, 2H); 13C NMR  14.88, 15.60, 27.47, 64.45, 69.14, 111.79, 124.38, 126.17, 129.34, 132.86, 










From 25, compound 40 was achieved after a flash chromatography (acetone: petroleum ether 
1:2) as a white solid (0.64 g, 56%): mp 162°C; 1H NMR  4.82 (m, 4H), 5.31 (dd, J = 1.6; 12.4 
Hz, 2H), 5.51 (dd, J = 1.6, 18.8 Hz, 2H), 6.16 (m, 2H), 7.31(d, J = 9.2, Ar, 2H), 7.92 (dd, J = 
2.4, 9.2 Hz, Ar, 2H), 7.98 (d, J = 2.4 Hz, Ar, 2H), 10.54 (s, 1H); 13C NMR  69.25, 114.30, 
117.20, 125.23, 132.08, 133.00, 133.74, 160.36, 188.44, 205.27; Anal. Calcd. for C20H18O4: C, 










Methyl-tributylammonium permanganate (MTBAP) [31] (0.49 g, 1.5 mmol) in dry 
dichloromethane (15 mL) was added at room temperature, dropwise and under N2 to a solution 
of 22 (0.5 g, 3 mmol) in dry dichloromethane (20 mL). Thereaction mixture was stirred at 20°C 
for 1 h and then was washed with an aqueous solution of Na2S2O5 (50 mL). The organic layer 
was separated, washed with water, dried over Na2SO4 and rotoevaporated to give as a  brown 
solid. Purification by flash chromatography using a 1:1 mixture of ethyl acetate:petroleum ether 
as eluent gave 23 as white solid (0.22 g, 46%): mp 83–84 °C; 1H NMR  2.14 (s, 6H), 2.70-
2.01 (series of m, 8H), 6.88 (d, J = 7.6 Hz, Ar, 2H), 7.10 (dd, J = 2.4, 7.6 Hz, Ar, 2H), 7.13 (d, 
J = 2.4 Hz, Ar, 2H); 13C NMR  28.08, 30.15, 45.35, 116.96, 125.24, 129.21, 131.22, 133.63, 








A solution of 4,4’-biphenol (0.20 g, 1.1 mmol) and hexamethylenetetramine (0.2 g, 1.3 mmol) 
in TFA (3 mL) was heated at 100°C for 10 min under microwave irradiation (100 W). The 
reaction mixture was extracted with dichloromethane (2 x 30 mL); the organic phase was 
washed with NaHCO3 solution, dried over Na2SO4 and evaporated. The crude product was 
washed with EtOH to eliminate impurities to give compound 25 as yellow solid (0.16 g, 60%): 
mp 106-107 °C (Lit.53 106-108 °C); 1H NMR (acetone d6)  7.10 (d, J = 8.8 Hz, 2H), 7.93 (dd, 
J = 2,4 and 8.8 Hz, 2H), 8.11 (d, J = 2.4 Hz, 2H), 10.13 (s, 2H); 13C NMR (acetone d6): δ 
117.83, 121.24, 131.22, 131.30, 134.80, 160.59, 197.09; Anal. Calcd. for C14H10O4: C, 69.42; 




Cs2CO3 (0.47 g, 1.5 mmol), Pd (OAc)2 (0.06 g, 0.29mmol) and 3-methylpent-1-en-3-ol (0.58 
g, 5.8 mmol) were added to a solution of 2-bromophenol (0.5 g, 2.9 mmol) in DMF (10 mL). 
The mixture was stirred under MW irradiation for 20 min at 100 W and 100°C. The reaction 
mixture was diluted with Et2O and washed with brine. The organic layer was dried over 
Na2SO4, and rotoevaporated. The product was purified by flash-chromatography on silica gel 
using a 1:3 mixture of ethyl acetate: petroleum ether as eluent to give product 26 (0.23 g, 42%): 
mp 108-109°C; 1H NMR (acetone d6)  0.91 (t, J = 7.6 Hz, 3H), 1.31 (s, 3H); 1.62 (q, J = 7.6 
Hz, 2H); 2.84 (bs, OH); 6.31 (d, J = 16.4 Hz, 1H); 6.8 (td, J = 0.8, 7.2 Hz, 1H); 6.86 (dd, J = 
0.8, 8 Hz, 1H); 6.91 (d, J = 16.4 Hz, 1H); 7.03 (td, J = 1.2 and 8.0 Hz, 1H); 7.41 (dd, J = 1.2, 8 
Hz, 1H), 8.37 (bs, OH); 13C NMR  8.36, 27.69, 35.38, 51.70, 115.92, 120.82, 121.77, 124.22, 






A solution of compound 42 (0.5 g, 1.45 mmol) in DMF (30 mL) Cs2CO3 (0.94 g, 2.9 mmol), 
Pd(OAc)2 (0.097 g, 0.145 mmol) and 3-methylpent-1-en-3-ol (0.58 g, 5.8 mmol) was stirred 






with Et2O and washed with brine. The organic layer, dried over Na2SO4, was concentrated 
under vacuum. The product was purified by flash-chromatographed on silica gel eluting with 
3:1 mixture of petroleum:ethylacetate to give product 27 (0.2 g, 40%): mp 130°C; 1H 
NMR(acetone d6)  0.92 (t, J= 7.2 Hz, 4H), 1.32 (s, 6H), 1.62 (q, J = 7.2 Hz, 6H), 3.52 (bs, OH, 
2H), 6.47 (d, J = 16.0 Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 7.28 (dd, J = 2.0, 8.8 Hz, 2H), 7.64 (d, 
J = 2.0 Hz), 8.49 (bs, OH, 2H); 13C NMR  7.89, 27.37, 35.42, 72.35, 115.94, 121.61, 124.65, 
124.73, 126.01, 132.79, 137.60, 153.55; Anal. Calcd. for C24H30O4: C, 75.36; H, 7.91; Found: 




A mixture of 2-(allyloxy)benzaldehyde [32] (0.20 g, 1,2 mmol), apocynin (0.2 g, 1.2 mmol) 
and LiOH (0.17 g, 7.4 mmol) in MeOH (5 ml) was subjected, in a 30 mL glass pressure 
microwave tube, equipped with a magnetic stirrer bar, to microwave irradiation (power: 100 
W; temperature: 70°C) for 15 min. The reaction mixture was then acidified with HCl 10% 
solution and extracted with dichloromethane (2 x 30 mL). The organic solution was dried over 
Na2SO4 and roto evaporated. The product was purified by flash chromatography using a 4:1 
petroleum ether:acetone mixture as eluent, to obtain compound 28 as a yellow solid. (0.2 g, 
53%): mp 94°C; 1H NMR  3.96 (s, 3 H), 4.63 (d, J = 5.2 Hz, 2H), 5.44 (dd, J = 1.2, 17.2 Hz, 
2H), 6.10 (m, 1H), 6.91 (d, J = 8.0 Hz, Ar, 1H), 6.97 (m, Ar, 2H), 7.34 (t, J = 1.6 Hz, Ar, 1H), 
7.65 (m, Ar, 3H), 7.71 (d, J = 16 Hz, 1H), 8.14 (d, J = 16 Hz, 1H). 13C NMR  56.10, 69.10, 
110.53, 112.49, 113.72, 117.99, 120.94, 122.72, 123.64, 124.34, 129.57, 131.25, 131.41, 
132.87, 139.67, 146.49, 150.19, 157.75, 189.22; Anal. Calcd. for C19H18O4: C, 73.53; H, 5.85; 





A mixture of compound 40 (0.26 g, 0.82 mmol), apocynin (0.29 g, 1.8 mmol) and LiOH (0.41 
g, 9.8 mmol) in MeOH (10 ml) was subjected to microwave irradiation (power: 70 W; 
temperature: 70°C) for 30 min in a 30 mL glass pressure microwave tube. The reaction mixture 
was then acidified with HCl 10% solution and extracted with dichloromethane (2 x 30 mL). 
The organic phase was dried over Na2SO4 and evaporated. Crude purification by flash 






yellow solid (0.2 g, 40%): mp 204°C; 1H NMR  3.93 (s, 6H), 4.78 (m, 4H), 5.33-5.37 (series 
of m, 2H), 5.51-5.56 (series of m, 2H), 6.22 (m, 2H), 6.95 (d, J = 8.4 Hz, Ar, 2H), 7.20 (d, J = 
8.8 Hz, Ar, 2H), 7.70 (d, J = 1.2 Hz, Ar, 2H), 7.73 (dd, J = 1.2; 10.8 Hz, Ar, 2H), 7.81 (dd, J = 
1.2; 10.0 Hz, Ar, 2H), 8.05 (d, J = 16 Hz, 2H), (d, J = 8.8 Hz, Ar, 2H), 8.2 (d, J = 16 Hz, 2H), 
8.22(d, J = 2.4 Hz, Ar, 2H); 13C NMR  55.43, 69.13, 111.19, 113.18, 114.56, 117.12, 122.70, 
123.46, 124.51, 126.88, 129.64, 130.80, 132.91, 133.52, 137.84, 147.66, 151.42, 156.94, 




To a solution of 2 (allyloxy) benzaldehyde [32] (1 g, 6.2 mmol) and 3,4-dimethoxy 
acetophenone (1.1 g, 6.2 mmol) in MeOH (10 mL) a solution of LiOH (0.89 g, 37.2 mmol) in 
MeOH (5 ml) was added dropwise. The reaction mixture was stirred at reflux for 12 h. The 
solution was acidified with HCl10% solution and extracted with dichloromethane (2 x 30 mL). 
The organicphases were dried over Na2SO4 andconcentrated in vacuo. The crude product was 
purified by flash chromatography using dichloromethane as eluent to give product 30 as a white 
solid (1.25 g, 62%): mp 87-88°C; 1H NMR  3.95 (s, 3 H), 3.96 (s, 3 H), 4.61 (d, J = 5.2 Hz, 
2H), 5.26-5.47 (series of m, 2H), 6.08 (m, 1H), 6.88 (d, J = 8.0 Hz, Ar, 1H), 6.97 (t, J = 6.8 Hz, 
Ar, 1H), 7.31 (dt, J = 1.6, 4.8 Hz, Ar, 1H), 7.60-7.68 (series of m, Ar, 4H), 7.70 (d, J = 16 Hz, 
1H), 8.10 (d, J = 16 Hz, 1H). 13C NMR  55.97, 56.05, 69.14, 109.97, 110.79, 112.46, 117.96, 
120.92, 122.64, 122.97, 124.29, 129.58, 131.42, 131.54, 132.86, 139.65, 149.07, 153.02, 







In a glass pressure microwave tube, a mixture of compound 40 (0.5 g, 1.6 mmol), 3,4-
dimethoxyacetophenone (0.6 g, 3.4 mmol) and LiOH (0.78 g, 18.6 mmol) in MeOH (10 ml) 
was subjected to microwave irradiation (power: 70 W; temperature: 70°C) and stirred for 30 
min. The reaction mixture was then acidified with HCl 10% solution and extracted with 






Purification by flash chromatography using a 7:3 petroleum ether: acetone mixture as eluent 
gave product 31 as a yellow solid. (0.16 g, 31%): mp 145-146°C; 1H NMR  3.95 (s, 3H), 3.97 
(s, 3H), 4.70 (d, J = 5.6 Hz, 4H), 5.33-5.57 (series of m, 4H), 6.22 (m, 2H), 6.94 (d, J = 8.0 Hz, 
Ar, 2H), 7.02 (d, J = 8.0 Hz, Ar, 2H), 7.54 (dd, J = 2, 8.4 Hz, Ar, 2H), 7.64 (m, Ar, 2H), 7.71 
(dd, J = 1.2, 8.4 Hz, Ar, 2H), 7.79 (d, J = 16 Hz, 2H), 7.82 (d, J = 2 Hz, Ar, 2H), 8.14 (d, J = 
16 Hz, 2H), 8.22(d, J = 2.4 Hz, Ar, 2H); 13C NMR  56.04, 56.07, 69.42, 110.01, 110.85, 
112.95, 118.16, 123.09, 123.20, 124.71, 127.97, 129.65, 131.51, 132.80, 133.16, 139.58, 









In a glass pressure microwave tube, ethyl vanilline (0.1 g, 0.6 mmol), iron sulfate heptahydrate 
(0.0075 g, 0.03 mmol) and potassium peroxodisulfate (0.081 g, 0.3 mmol) in water (5 ml) were 
subjected, with stirring, to microwave irradiation (power: 100 W; temperature:110°C) for 10 
min. The reaction mixture was then acidified with HCl 10% solution and extracted with 
dichloromethane (2 x 30 mL). The organic solution was dried over Na2SO4 and evaporated. 
The product was purified by chromatography on a column of silica gel with a mixture of 1:4 
petroleum ether: ethyl acetate as eluent to give compound 39 as a yellow solid (0.51 g, 52%): 
mp 236-237°C; 1H NMR  1.49 (t, J = 6.8 Hz, 6H), 4.23 (q, J = 6.8 Hz, 4H), 6.6 (bs, 2H), 7.42 
(d, J = 1.6 Hz, Ar, 2H), 7.50 (d, J = 1.6 Hz, Ar, 2H); 13C NMR  14.71, 65.13, 108.71, 113.89, 
120.76, 129.26, 131.48, 143.23, 190.48; Anal. Calcd.for C18H18O6: C, 65.45; H, 5.49; Found: 









To a solution of 5,5',6,6'-tetramethoxy-[1,1'-biphenyl]-3,3'-diol [14] (1.17 g, 3.8 mmol) and 
K2CO3 (2 g, 11.4 mmol) in dry DMF (30 mL), methyl bromoacetate (1.50 g, 8.4 mmol) was 
added. The mixture was stirred at rt for 72 h and then water and 10% HCl were added. The 
precipitate was filtered to obtain  43 as a yellow solid (1.62 g, 95%): mp 132-133°C; 1H NMR 
 3.56 (s, 6H), 3.78 (s, 6H), 3.86 (s, 6H), 4.57 (s, 4H), 6.31 (d, J = 2.4 Hz, Ar, 2H), 6.61 (d, J = 
2.4 Hz, Ar, 2H); 13C NMR  52.21, 55.84, 60.74, 65.60, 100.92, 106.34, 132.27, 141.53, 153.51, 





To a solution of 43 (1.32 g, 2.9 mmol in dry THF (25 mL), lithium hydroxide (0.50 g, 11.7 
mmol) was added under N2. The solution was stirred for 12 h at 70 °C. 10% HCl and water 
were added, the mixture was extracted with diethyl ether (2x50 mL). The organic phases were 
dried and evaporated to get 44 as a white solid (1.20 g, 98%): mp 183–184°C; 1H NMR  3.52 
(s, 6H), 3.83 (s, 6H), 4.67 (s, 4H), 6.37 (d, J = 2.1 Hz, Ar, 2H), 6.63 (d, J = 2.1 Hz, Ar, 2H); 
13C NMR  55.26, 59.73, 64.97, 100.32, 106.99, 132.99, 141.36, 153.55, 153.81, 169.46; Anal. 




In a 25 mL flask, 8 g of polyphosphoric acid were weighed in and were heated at an oil bath 






was carried out for 3 hrs at 90 °C. The cooled solution was poured onto ice. After stirring during 
2 hours, three extractions were carried out with a total of 400 mL of dichloromethane. The 
organic phases, washed with water and 10% K2CO3 solution, were dried over Na2SO4. After 
removal of the solvent, the residue was purified by chromatography on a column of silica gel 
using a 1:1 mixture of ethyl acetate:petroleum ether as eluent to get 37 as a yellow solid (0.24 
g, 90%): mp 138–140 °C; 1H NMR  3.59 (s, 6H), 3.92 (s, 6H), 4.52 (AB system, J = 17.6 Hz, 
4H), 6.65 (s, Ar, 2H); 13C NMR  56.24, 60.96, 75.45, 96.07, 111.35, 124.01, 142.56, 161.24, 







2-bromopropane (1.5 g, 12.4 mmol) was added to a mixture of compound 3 (2 g, 10.3 mmol) 
and K2CO3 (1.7 g, 12.4 mmol) in dry acetone (30 mL). The reation mixture  was stirred at 60 
°C for 12 hrs, filtered and evaporated. The resulting solid was treated with dichloromethane (50 
mL) and an 10% NaOH acqueous solution (30 mL). The organic phase was dried over Na2SO4 
and evaporated to get 38 as a colourless oil (1.48 g, 61%); 1H NMR  1.31 (d, J = 6.4 Hz, 6H), 
2.10 (s, 3H), 2.68-2.82 (series of m, 4H), 3.79 (s, 3H), 4.44 (sept,J = 6.4 Hz, 1H), 6.66 (dd, J = 
2, 8 Hz, Ar, 1H), 6.68 (d, J = 2 Hz, Ar, 1H), 6.77 (d, J = 8.0 Hz, Ar, 1H); 13C NMR  22.10, 
29.36, 30.04, 45.35, 55.86, 71.51, 112.36, 116.24, 120.06, 134.13, 145.53, 146.16, 150.35, 
208.11; Anal. Calcd. for C14H20O3: C, 71.16; H, 8.53; Found: C, 71.20; H, 8.56. 
 
Table I. Structural formulas of tested compounds and Oxy Score values  
 
Evaluation of the antioxidant potential (pro-oxidant/antioxidant activity) of the 36 
compounds  
Healthy volunteers who had attended their regular medical check-up at the Military Medical 
Academy in Belgrade and had given approval that any serum left over after biochemical 
analyses planned by physicians could be used for this study. Fifty samples whose basic 





mixing the serum pool was aliquoted into 450 µL portions and frozen at -83°C until analyses 
took place. 
The stock concentration of each of the compounds was 10mg/mL. DMSO was the solvent. All 
analyses were performed in triplicate. To 450 µL of serum 50 µL of each compound under 
investigation was added (500 µL total) and then incubated at 37°C for 2h.  
The same procedure was implemented at the samples with concomitant presence of tested 
substances and tert-butyl-hydroperoxide (TBH) (0.5µL/mL solution in distillate water) as pro-
oxidant substance.  
Total Oxidative Potency (TOP) 
TOP was determined according to Erel [33] and Kotur-Stevuljevic et al. [34]. All oxidants in 
the sample (for example H2O2 and lipid hydroperoxides) oxidise a ferro-orthodianisidin 
complex to ferric ion in an acidic environment in the presence of glycerol. The resulting ferric 
ion forms a coloured complex with xylene-orange. Colour intensity is measured 
spectrophotometrically (A 560nm) and is proportional to the total content of oxidising 
molecules in the sample.The assay is calibrated with H2O2 (10-200 μmol/L) and the results were 
expressed μmol H2O2 Equiv/L. 
Pro-oxidant-Antioxidant Balance (PAB) 
The PAB indicates concomitant pro-oxidant load and antioxidative capacity of a particular 
organism. A modified version of a published method [35] was used for PAB determination. 
The assay determines the concentration of H2O2. The chromogen 3,3',5,5'-tetramethylbenzidine 
(TMB) reacts with both, H2O2 and antioxidants, (including uric acid and other reducing 
species). The reaction between H2O2 and chromogen is catalysed by the enzyme peroxidase, 
resulting in the oxidation of TMB to produce an intense colour. In contrast, the reaction between 
uric acid and similar compounds with chromogen is non-catalyzed not driven by peroxidase 
causing discolouration. The colour generated in the reaction is proportional to the ratio of pro-
oxidants and antioxidants. Absorbance was read at 450 nm after a 10 minute incubation of the 
reaction medium at 370C. 
SH-groups (SHG) 
Total sulphydryl groups in serum was determined by a modification of Ellman’s method [36] 





product between 2,2'-dinitro-5,5'-dithiobenzoic acid (DTNB) and aliphatic thiol compounds in 
basic conditions (pH = 9.0). Absorbance was measured at 412 nm. 
Total Antioxidant Capacity (TAC) 
TAC was measured using the stable ABTS+ cation as a chromogen [37]. ABTS is oxidised by 
H2O2 in acetate buffer; pH = 3.6 to a green coloured ABTS
+ cation. Antioxidants present in the 
sample lead to varying degrees of discoloration proportional with their concentration (the 
antioxidant potential of the sample). After incubation for 10 minutes at room temperature 
absorbance at 600nm was recorded.  
Pro-oxidative Score, Antioxidative Score and Oxy Score 
Overall oxidative stress was evaluated through several scores: Protective, damage and Oxy 
Score as previously suggested [38]. Antioxidative Score (indicating protective capacity) was 
calculated as the mean of the Z Scores of the measured antioxidant parameters - TAC and SHG. 
Pro-oxidative Score (indicating damaging potential) was calculated as mean Z Scores of the 
measured pro-oxidant parameters - TOP and PAB. Oxy Score was calculated as the difference 
between Pro-oxidative and Antioxidative Scores. Population parameters for Z scores 
calculation were from our previous investigations using a healthy population.The formula for 
Z score calculation was as follows: (xi – x̄)/σ, where xi is sample value, x̄ - population mean, σ 
– population standard deviation. A higher Oxy score indicates less antioxidative protection, in 
other words a more pronounced pro-oxidative state. 
Statistical analysis 
The results of all parameters were expressed as percentiles (medians with 25th and 75th 
percentile values). The non-parametric Kruskall-Wallis test with post hoc Mann-Whitney U test 
with Bonferroni correction  was used for statistical analysis. Values of p<0.05 were considered 
as statistically significant. 
Results  
The material for antioxidant potential assays comprises of 36 compounds (monomers or their 
C2-symmetric dimers) which synthesis started, for almostall of them, from naturally occurring 
compounds commercially available (Table I) and following methods known in literature or 
improving them by sustainable reagents and procedures. Compound 1 was prepared by 






presence of neutral alumina (with good yield). The same procedure was followed for the 
preparation of dimer 2, starting from the corresponding benzofuran-3-one dimer. Compound 5 
was prepared in one pot (in 60% yield) by a coupling reaction of 4-(4-isopropoxy-3-
methoxyphenyl)butan-2-one in the presence of molybdenum (V) chloride. The coupling 
reaction of monomer 10 in the presence of methyl-tributylammonium permanganate at room 
temperature produced dimer 11 (in 61% yield). Claisen-Schmidt condensation of 5,5'-diethoxy-
6,6'-dihydroxy-[1,1'-biphenyl]-3,3'-dicarbaldehyde with acetone under basic conditions gave 
compound 13 (in 80% yield). Following the same reaction conditions, compound 21 was 
prepared starting from per-O-acetylated β-C-glucopyranosyl ketone and 5,5',6,6'-tetramethoxy-
[1,1'-biphenyl]-3,3'-dicarbaldehyde and further deacetylation (with 73% of overall yield). 
Following the same procedure, compound 20 was prepared (in 80% yield) starting from 
veratraldehyde. Compounds 14, 15, 17, 18, 19 and 40 were obtained by protection of the 
corresponding phenolic hydroxyl group with the appropriate organohalide under basic 
conditions, in acetone at reflux. The coupling reaction of raspberry ketone 22 in the presence 
of methyl-tributylammonium permanganate as catalyst gave dimer 23. Microwave procedures 
were applied for the preparation of compound dimers 25-29, 31 and monomer 26 following 
different reaction conditions. Dimer 25 was prepared (in 60% yield) starting from the 
commercial 4,4’-dihydroxy biphenyl and hexamethylenetetramine in the presence of 
trifluoroacetic acid. A palladium catalysed Heck reaction between 3-methylpent-1-en-3-ol and 
2-bromophenol under basic conditions gave compound 26. Following the same procedure for 
26 and starting from the corresponding dimer dibromide, compound 27 was obtained (in 40% 
yield). Apocynin and 4,4'-bis(allyloxy)-[1,1'-biphenyl]-3,3'-dicarbaldehyde in the presence of 
lithium hydroxide in methanol produced dimer 29 (in 40% yield) after 30 min of microwave 
irradiation. Following the same procedure of 29, compound 31 was obtained (in 31% yield) 
starting from 4,4'-bis(allyloxy)-[1,1'-biphenyl]-3,3'-dicarbaldehyde and 3,4-
dimethoxyacetophenone. Monomer 30 was prepared (in 62% yield) following Claisen-Schmidt 
condensation of 3,4-dimethoxy-acetophenone and 2-(allyloxy)benzaldehyde under basic 
conditions. 
Based on the values of the calculated Prooxidative scores and the calculated Antioxidative 
scores expressed together as Oxy score (Table I), six compounds were found to have strong 
antioxidant properties: 6, 7, 12, 13, 26, and 27 and four compounds were found to have 






results of all the distinct redox status markers measured in our current study using the in vitro 
assays. 
 
Table II Redox status parameters measured after the reaction of polyphenolic 
compounds with serum 
 
A group of weak antioxidants (compounds 2, 29-31) caused a significant increase in both PAB 
and TOP parameters compared to a group of strong antioxidants (compounds 6, 7, 12, 13, 26 
and 27). Strong antioxidants significantly increased TAC values compared to weak 
antioxidants. After addition of exogenous pro-oxidant TBH in samples containing strong 
antioxidants, we noticed a decrease in TOP concentration for compounds 6, 12 and 13, whereas 
for compounds 7 and 27 TOP concentration was unaffected. Compound 26 unexpectedly 
increased TOP. Because of obvious interactions between Ellman’s reagents with polyphenolic 
compounds we omitted SHG from the calculation of the Antioxidative scores. When comparing 
the same parameters in the weak antioxidant compound group before and after TBH addition 
we found that PAB and TOP both diminished. All differences were significant (p<0.05). 
Unexpectedly TAC increased after TBH addition in the weak antioxidative compound group 
(p<0.05).  
Regarding influence of TBH addition in samples of strong antioxidant groups we noticed 
significant increase in PAB values only for the 26 substance (p<0.05).  PAB parameter 
remained at the basic level (without TBH) for the other five strong antioxidants. 
Trolox was used as a control, a known and characterized antioxidative substance. In our assay 
it’s antioxidative activity was found to lie between that of the weak and strong groups of 
compounds. The Oxy Score values of the strong antioxidative compounds ranged from      -28.8 
± 0.4 to -32.5 ± 1.1, while the Oxy Score values of weaker antioxidative compounds were 
significantly more positive and ranged from 11 ± 0.7 to 14.6 ± 0.8. The Oxy Score for Trolox 
was -7.01 (-7.53– -6,51), so it was clearly positioned between strong and weak antioxidative 
compounds. There was a statistically significant difference in the Oxy Score between all strong 
antioxidative compounds and all weak antioxidative compounds (p<0.001). This was also true 
for strong antioxidative compounds andTroloxand weak antioxidative compounds and Trolox, 
both (p<0.01).Figures 1 and 2 show the results of 6 strongest antioxidative compounds and 4 






parametric Kruskall-Wallis and post hoc Mann-Whitney U test it was found that there was no 
statistically significant difference (p>0.05) in the values of the Oxy Score (antioxidant activity 
capacity) of the 6 strongest antioxidative compounds [in assays without TBH (Fig. 1) and in 
those with TBH added (Fig. 2)]. 
Lipophilicity (LogP) of the strongest antioxidative compounds in serum (compounds 6, 7, 12, 
13 and 26) varied between 1.27 and 2.85 whereas higher LogPs value were calculated for the 
weakest antioxidative compounds (compounds 2, 29, 30, 31) in the range of 3.90 - 7.44. 
A similar trend was calculated in the series of antioxidants and pro-oxidants assayed without 
addition of human serum (Table I). Trolox’s LogP value (3.19) was close to the series of 





Results of in vitro analysis in samples in non-biological matrix (direct reaction of selected 
polyphenolic compounds with reagents for TAC, TOP and PAB determination, without 
addition of human serum), with a statistically significant difference between the parameters 
determined (p<0.001), compounds 3, 4, 6, 10, 11 and 12 were found to be the most effective 
antioxidants, while compounds with weakest antioxidant activity were 17, 19, 30 and 34 (Figure 
3). There was no statistically significant difference in the group of the six newly selected potent 
antioxidants (p>0.05). Figure 3 shows the obtained values of the six strongest antioxidative 





Our results so far have identified the 6 strongest antioxidative compounds and the 4 weakest 
antioxidative compounds. Strongest: Dehydrozingeronederivates, monomers or dimers, 





(dimers)], prenylated phenol and 4,4'-dihydroxybiphenyl derivative [compounds 26 (monomer) 
and 27 (dimer)]. Weakest: Aurone and chalconederivatives [compounds 2, 29 and 31 (dimers)] 
and one chalcone monomer (compound 30). 
The strongest in vitro antioxidant activity in matrix in the absence of human serum was that of 
zingerone (compounds 3 and 4, monomer and dimer, respectively), dehydrozingerone 
(compound 6), an ethylvanyllin 3-buten-2-one derivative monomer (compound 12) and the 
vanillyl alcohol methyl esters monomer (compound 10) and dimer (compound 11). The weakest 
antioxidants was the dehydrozingeronedimer derivative (compound 17), a dimer of 
ethylvanylin 3-buten-2-one derivative (compound 19), a methylmagnolol derivative 
(compound 34) and a chalcone derivative (compound 30). 
It is important to note that compounds 6 and 12 (strong antioxidative activity) and compound 
30 (weak antioxidant activity) manifested equal activity both in the absence and presence of 
human serum. 
Discussion 
The pro-oxidant/antioxidant activity of polyphenolic compounds is dependent on various 
factors including metal-reducing potential, chelation properties, pH, solubility and 
concentration [19]. Such factors together with polyphenolic compound bioavailability and 
stability in biological environments, need be considered when evaluating their potential 
antioxidant bioactivity [17, 40]. There has been many polyphenolic compounds investigated 
so far for potential use in human medicine, but resveratrol became especially appreciated 
primarily for its antioxidant and anti-inflammatory potency. However, Chudzińska et al. 
concluded that its beneficial effects are still not clearly confirmed and that there is a need for 
the further and better controlled clinical studies [41]. On the other side, Patti et al. [42] 
confirmed beneficial effects of olive oil, as phenolic compound, on anthropometric and 
biochemical parameters, including inflammatory markers in patients with metabolic syndrome 








Molecules having two symmetric binding moieties bearing a flexible bridge of suitable length 
and properties, would be expected to show a higher target binding affinity leading to higher 
biological activity compared with molecules where one binding moiety is missing [21, 43, 44]. 
Due to their specific structure, hydroxylated biphenyls have been found to have better 
antioxidant effects than the corresponding monophenols [17, 39, 45]. The results obtained in 
our study confirm the finding that the strongest antioxidant effect in the (serum-containing) 
biological environment was achieved by compounds containing a free phenolic hydroxyl as an 
electron-donating group with a ethoxy/methoxy in orthoposition and the side chain with an α,β-
unsaturated ketone, which contributes to the stability of phenoxyl radicals by increasing 
electronic delocalisation in the bio-environment [18].  
But interestingly, our results showed that dehydrozingerone monomer (compound 6) and 
ethylvanyllin 3-buten-2-one derivative (compound 12) exhibited better antioxidant effect than 
their corresponding dimers, even though an almost comparable Oxy Score was calculated for 
the corresponding dimers (compounds 7 and 13, respectively). The difference in the antioxidant 
activity of the dimers could have been due to the formation of intramolecular hydrogen bonds 
and reduced rotation (appearance of axial chirality) that hinders electronic delocalisation of the 
phenoxyl radical through the two non planar aromatic rings [46].  
Vitamin E family, known as tocopherols, are methyl-substituted tocol derivatives. The most 
potent is α-tocopherol (5,7,8-trimethyltocol) which contains three electron-donating methyl 
groups that increase the nucleophilicity and reactivity of the phenolic group at position 6 of the 
chromane ring. Additionally, resonance stabilization by the para oxygen in the chromane ring 
improves the stability of the α-tocopherol radical [47].   
One of the primary function of vitamin E is preventing the oxidation of lipids, particularly 
unsaturated fatty acids through its antioxidant effects. Vitamin E is a fat-soluble compound and 
penetrates biological membranes. Located in cell membranes, vitamin E could act toward 
reactive oxygen species (ROS), thus protecting cellular components from oxidative damage 
[47]. The α-tocopherol donates its electrons to the free radicals to neutralize them,  In this 
process, α-tocopherol is fully oxidized to the α-tocoquinone form and loses its antioxidant 
capacity. 
Trolox is a water soluble analogue of α-tocopherol, used as a reference in the evaluation of 






Lipophilicity of Trolox and compounds 1-36 was estimated by ChemBioDraw Ultra 13.0 
software (CambridgeSoft) expressed as LogP (the logarithm of the partition coefficient for n-
octanol/water)  and listed in Table I. Although a carboxylic group is present in the structure of 
Trolox, the high logP value of the compound (3.19) implies a lipophilic character, as already 
documented in another study [20]. The physicochemical property of Trolox would explain the 
high affinity of the compound towards cellular membranes [48], but also could elucidate Trolox 
affinity towards lipoprotein particles i.e. their lipid content.We could hypothesise a different 
partition of Trolox in the bilayer surface that influencesthe interactions of the compound with 
peroxyl radicals generated in a selected experimental method. This point offers an explanation 
for the medium antioxidativeTrolox activity positioned between strong and weak polyphenolic 
compounds analysed in this study. 
An unexpectedly high antioxidant effect was exhibited by compound 26 which lacks in a 
guaiacyl unit and an α,β-unsaturated methyl ketone side chain as in compounds 6 and 12. It is 
possible that both in serum, and under acidic or basic conditions, compound 26 could undergo 
elimination of water by proton removal from the methylene group of the allylic chain and 
subsequent formation of a prenylated unit that would stabilise the phenoxyl radical. Good 
antioxidant activity of this structural moiety was also confirmed in the corresponding dimer, 
compound 27. 
Although there have been many studies in animal models using zingerone as antioxidant and 
anti-inflammatory compound [49], our results indicate that zingerone (compound 3) exhibited 
greater antioxidant activity in an assay without biological material (human serum).  
Zingerone exhibits good radical-scavenging activity but poorly acts as a chain-breaking 
antioxidant in lipid auto-oxidation in comparison with dehydrozingerone 6 and its 
corresponding dimer 7. Lipophilic antioxidants play a crucial role in attenuating oxidative 
processes that occur in cell membranes in diseases including cancer and neurodegeneration [49-
51]. 
We found that lipophilicity of the strongest antioxidants detected in human serum was lower in 
comparison to that of the weakest antioxidants which contained a protected alkyl phenolic-
hydroxyl group. It is possible that hydrolytic enzymes present in human serum are not able to 
deprotect the alkylated phenolic-hydroxyl group that could occur in other biological system. 
Raspberry ketone, compound 22, one of the main components of red berry fruits and responsible 






compound 22, lacking in methoxyl group in ortho position to the phenolic-hydroxyl group and 
an α,β-unsaturated lateral chain, did not achieve a calculated oxy score value as great as 
dehydrozingerone 6. Nevertheless, raspberry ketone has been considered a health-promoting 
compound and marked as food supplement [55]. 
Chalcones are a group of polyphenolic compounds that have recently been used as additives 
and ingredients in cosmetic preparations because of their potential high antioxidant and anti-
inflammatory effects [56,57]. However, the tested compounds in our study, which are 
monomers and dimers of chalcones and aurones (formed by cyclisation of chalcones), namely 
compounds 2, 29, 30 and 31, exhibited the weakest antioxidant properties. The reason for this 
is probably the small number and/or absence of free phenolic hydroxyl groups in the molecule 
(which are mandatory for the antioxidant action of polyphenols), their too high lipophilicity or 
their inadequate configuration. 
Regarding part of results which showed comparison before and after TBH addition and opposite 
activity in a group of weak compared to strong antioxidants could be explained with the lack of 
any prooxidative capacity in weak antioxidants which could, according to Halliwell initiate 
triggering of fast and strong antioxidative response of biological medium [58,59].  
Conclusion  
From a diverse group of tested natural-like polyphenolic compounds comprising of zingerone, 
dehydrozingerone, aurone, chalcone, magnolol derivatives, monomers and their corresponding 
dimers, the greatest antioxidant activity was that of dehydrozingerone analogues (compounds 
6 and 12). In the future we will focus on these two moieties to confirm their mechanism of 
antioxidant action. The results suggest that those compoundg could be candidates for the 
curcumin analogues that potentially improves its bioavailability in vivo. The most convincing 
confirmation of their antioxidative potency also comes from the results of the same activity 
achieved by the well-known antioxidant Trolox, which is a water-soluble vitamin E analogue. 
Trolox’s activity was found between the strong and weak antioxidant compounds analysed in 
our study. This means that compounds 6 and 12 are worthy of further investigation in the 
antioxidant biology.  
The inconsistency of our results regarding the antioxidant effects of the compounds in different 
matrices (human serum and in vitro environment without bio-matrix) supports the 
unpredictability of polyphenolic pharmacophore behaviour in a biological environment and the 






be good candidates for in-depth testing of their biological behaviour and for possible precursors 
for the synthesis of novel polyphenolic molecules for potential therapeutic applications.  More 
studies (animal and human or cell culture based) are necessary to provide evidence and to 
elucidate dose-response and cost-benefit relationships between polyphenol-like compounds, 
their therapeutic potential and health benefits. One of the limitation of this current study is 
acelular material used (human serum), but this is available biomaterial upon which we have 
developed platform for testing different substances' interaction with human origin 
biomolecules.  
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Table I Structural formulas of tested compounds and Oxy Score values  
























-14.68 (-16.39 – -12.97) 
1.95 










-17.65 (-18.10– -17.21) 
3.53 
386.44 
-8.11 (-8.27– -7.94) 
3.53 
192.21 


















-31.66 (-31.83– -31.48) 
2.17 
206.24 
-4.09 (-4.21– -3.97) 
1.53 
422.55 
-0.33 (-1.42– 0.76) 
2.70 










-14.47 (-22.67– -6.27) 
1.31 
334.37 
-6.05 (-6.25– -5.85) 
2,25 
206.24 
-32.47 (-33.27– -31.76) 
1.60 




















-17.36 (-18.33– -16.40) 
1.87 
438.52 
3.34 (0.97 – -5.70) 
3.37 


















-6.45 (-6.91– -6.00) 
2.20 

























-4.13 (-5.45– -2.82) 
-0.93 
734.35 
-4.42 (-4.65– -4.19) 
-2.22 

















-3.67 (-3.88– -3.47) 
1.39 





















-31.71 (-32.03– -31.40) 
2.61 
382.50 
-28.85 (-29.12– -28.57) 
4.86 












































-5.07 (-5.72– -4.42) 
5.03 
280.37 
-1.73 (-1.88– -1.58) 
5.30 











-1.23 (-1.49– -0.97) 
5.56 
308.38 
-2.85 (-3.56– -2.14) 
5.01 
350.41 























-7.01 (-7.53– -6,51) 
3.19 
*Auron derivatives: compounds 1(monomer) and 2 (dimer); zingerone derivatives: compounds 3 (zingerone, monomer), 4 (zingerone,dimer) and 5 (dimer); 
dehydrozingerone derivatives: compounds 6 (dehydrozingerone, monomer), 7 (dehydrozingerone,dimer), 8 (monomer) and 9 (dimer), 16 (OEt-dehydrozingerone, monomer), 
17 (OEt-dehydrozingerone, dimer); vanillyl alcohol methyl esters: compounds 10 (monomer) and 11 (dimer); ethylvanylin 3-buten-2-one derivatives: compounds 12, 14 and 
18 (monomers); 13,15 and 19 (dimers); glucosylateddehydrozingerone compounds: compounds 20 (monomer) and 21 (dimer); 4-(3-hydroxybutil-3-on) phenol (raspberry 
ketone): compounds 22 (raspberry ketone, monomer) and 23 (raspberry ketone, dimer); salicylaldehyde and its 4,4'-dihydroxybiphenyl derivative: compounds 24 (monomer) 
and 25 (dimer); prenylated phenol and 4,4'-dihydroxybiphenyl derivative: compounds 26 (monomer) and 27 (dimer); chalcones and 4,4'-dihydroxybiphenylchalcones: 
compounds 28 and 30 (monomers); 29 and 31 (dimers); magnolol: compound 32 (magnolol), and methylmagnolol derivatives: compounds 33 and 34; monoacetylmagnolol: 
compound 35, and diacetylmagnolol: compound 36. 
 


































































































































































































































p 0.049 0.035 0.077 0.041 0.049 0.033 0.065 0.038 
 



















Figure 1. The values of Pro-oxidative, Antioxidative, and Oxy Scores of six strong
(compounds 6, 7, 12, 13, 26, 27) and four weak (compounds 2, 29, 30, 31) antioxidants in
the serum matrix without TBH addition. The green solid line represents the value obtained
with Trolox (standard), the blue solid line represents values obtained with serum with DMSO
as solvent (control).





Figure 2. The values of Pro-oxidative, Antioxidative, and Oxy Scores of six strong
(compounds 6, 7, 12, 13, 26, 27) and four weak (compounds 2, 29, 30, 31) anti-oxidants in
the serum matrix with TBHaddition. The green solid line represents the value obtained with
Trolox (standard), the blue solid line represents values obtained with serum with DMSO as
solvent (control).





Figure 3. The values of Pro-oxidative, Antioxidative, and Oxy Scores of the 6 strongest
antioxidative compounds (3, 4, 6, 11, 12) and the 4 weakest antioxidative compounds (17,
19, 30, 34) in samples without addition of human serum.
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